[HTML] plos.org

[HTML][HTML] Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato… - PLoS one, 2013 - journals.plos.org
Background and Purpose The most common strategy for treating patients with acute
ischemic stroke is thrombolytic therapy, though only a few patients receive benefits because …
被引用次数：109 相关文章

[引用][C] Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato… - PLoS …, 2013 - ui.adsabs.harvard.edu
Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients -
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Relevance …

Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato… - PloS …, 2013 - pubmed.ncbi.nlm.nih.gov
Background and purpose The most common strategy for treating patients with acute
ischemic stroke is thrombolytic therapy, though only a few patients receive benefits because …
[PDF] scienceopen.com

[PDF][PDF] Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato - PLoS ONE, 2013 - scienceopen.com
Abstract Background and Purpose: The most common strategy for treating patients with
acute ischemic stroke is thrombolytic therapy, though only a few patients receive benefits …
[PDF] semanticscholar.org

[PDF][PDF] Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients

M Kaito, SI Araya, Y Gondo, M Fujita… - PLoS ONE, 2013 - pdfs.semanticscholar.org
Abstract Background and Purpose: The most common strategy for treating patients with
acute ischemic stroke is thrombolytic therapy, though only a few patients receive benefits …
[HTML] nih.gov

[HTML][HTML] Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato… - PLoS ONE, 2013 - ncbi.nlm.nih.gov
Background and Purpose The most common strategy for treating patients with acute
ischemic stroke is thrombolytic therapy, though only a few patients receive benefits because …

Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients.

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato… - PLoS …, 2013 - search.ebscohost.com
Abstract Background and Purpose: The most common strategy for treating patients with
acute ischemic stroke is thrombolytic therapy, though only a few patients receive benefits …
[PDF] psu.edu

[PDF][PDF] Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato - PLoS ONE, 2013 - Citeseer
Abstract Background and Purpose: The most common strategy for treating patients with
acute ischemic stroke is thrombolytic therapy, though only a few patients receive benefits …

Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients.

M Kaito, S Araya, Y Gondo, M Fujita, N Minato… - Plos one, 2013 - europepmc.org
Background and purpose The most common strategy for treating patients with acute
ischemic stroke is thrombolytic therapy, though only a few patients receive benefits because …
[PDF] researchgate.net

[PDF][PDF] Relevance of Distinct Monocyte Subsets to Clinical Course of Ischemic Stroke Patients

M Kaito, SI Araya, Y Gondo, M Fujita, N Minato - PLoS ONE, 2013 - researchgate.net
Abstract Background and Purpose: The most common strategy for treating patients with
acute ischemic stroke is thrombolytic therapy, though only a few patients receive benefits …